Trials / Completed
CompletedNCT00225485
Study Evaluating Effexor XR in Elderly Patients With Major Depression.
Phase III Study of Effexor XR for the Treatment of Elderly Patients With Depression
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 100 (planned)
- Sponsor
- Wyeth is now a wholly owned subsidiary of Pfizer · Industry
- Sex
- All
- Age
- 65 Years
- Healthy volunteers
- Not accepted
Summary
Phase III study evaluating Effexor XR in elderly patients with major depression.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Effexor XR |
Timeline
- Start date
- 2003-12-01
- First posted
- 2005-09-23
- Last updated
- 2007-05-28
Locations
37 sites across 1 country: Japan
Source: ClinicalTrials.gov record NCT00225485. Inclusion in this directory is not an endorsement.